Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Arocell AB Says Dialogue Has Been Held With FDA Regarding 510(K) Submission That Co Submitted On May 26

Sept 22 (Reuters) - AroCell AB (publ)  AROC.ST :
    * AROCELL AB -  DIALOGUE HAS BEEN HELD WITH U.S. FDA
REGARDING
510(K) SUBMISSION THAT CO SUBMITTED ON MAY 26, 2020
    * AROCELL AB - IN DIALOGUE WITH FDA, AROCELL RECEIVED
QUESTIONS
REGARDING 510(K) SUBMISSION
    * AROCELL AB  - INTENDS TO PROCESS QUESTIONS REGARDING
510(K)
SUBMISSION AND UPDATE APPLICATION WITHIN A FEW WEEKS

Source text for Eikon:  ID:nNDL8Dq0yV 
Further company coverage:  AROC.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on IDL Diagnostics AB (publ)

See all news